Medtronic plc (MDT)

Medtronic Income Statement

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020
Revenue	32,364	32,364	31,227	31,686	30,117	28,913
Revenue Growth (YoY)	3.64%	3.64%	-1.45%	5.21%	4.16%	-5.38%
Cost of Revenue	11,216	11,216	10,719	10,145	10,483	9,424
Gross Profit	21,148	21,148	20,508	21,541	19,634	19,489
Selling, General & Admin	10,736	10,736	10,415	10,292	10,148	10,109
Research & Development	2,735	2,735	2,696	2,746	2,493	2,331
Other Operating Expenses	2,532	2,532	1,912	2,750	2,509	2,258
Operating Expenses	16,003	16,003	15,023	15,788	15,150	14,698
Operating Income	5,145	5,145	5,485	5,753	4,484	4,791
Interest Expense / Income	719	719	636	553	925	1,092
Other Expense / Income	-383	-383	-489	-295	-312	-339
Pretax Income	4,809	4,809	5,338	5,495	3,871	4,038
Income Tax	1,133	1,133	1,580	456	265	-751
Net Income	3,676	3,676	3,758	5,039	3,606	4,789
Net Income Growth	-2.18%	-2.18%	-25.42%	39.74%	-24.70%	3.41%
Shares Outstanding (Basic)	1,328	1,328	1,330	1,342	1,345	1,341
Shares Outstanding (Diluted)	1,330	1,330	1,333	1,351	1,354	1,351
Shares Change	-0.20%	-0.20%	-1.38%	-0.19%	0.21%	-0.47%
EPS (Basic)	2.77	2.77	2.83	3.75	2.68	3.57
EPS (Diluted)	2.76	2.76	2.82	3.73	2.66	3.54
EPS Growth	-2.13%	-2.13%	-24.40%	40.23%	-24.86%	3.81%
Free Cash Flow	5,200	5,200	4,580	5,978	4,885	6,021
Free Cash Flow Per Share	3.92	3.92	3.44	4.45	3.63	4.49
Dividend Per Share	2.760	2.760	2.720	2.520	2.320	2.160
Dividend Growth	1.47%	1.47%	7.94%	8.62%	7.41%	8.00%
Gross Margin	65.34%	65.34%	65.67%	67.98%	65.19%	67.41%
Operating Margin	15.90%	15.90%	17.56%	18.16%	14.89%	16.57%
Profit Margin	11.36%	11.36%	12.03%	15.90%	11.97%	16.56%
Free Cash Flow Margin	16.07%	16.07%	14.67%	18.87%	16.22%	20.82%
Effective Tax Rate	23.56%	23.56%	29.60%	8.30%	6.85%	-18.60%
EBITDA	8,175	8,175	8,671	8,755	7,498	7,793
EBITDA Margin	25.26%	25.26%	27.77%	27.63%	24.90%	26.95%
Depreciation & Amortization	2,647	2,647	2,697	2,707	2,702	2,663
EBIT	5,528	5,528	5,974	6,048	4,796	5,130
EBIT Margin	17.08%	17.08%	19.13%	19.09%	15.92%	17.74%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).